Just another angle on why Bio have gone down the road of buying an existing drug company and/or are going to manufacturing their own generic drugs. I'm not convinced that this is entirely one in the eye for the big pharmas and a case of "if you don't believe us watch this" i suspect that the big pharmas ie. some of the "top ten" with whom we are talking to re:RNS are fully aware of the intentions of what appears to be happening and maybe are quite happy about it. After all if this turns out to be a profitable exercise for us, then it will not only serve our near term revenues but also finally show the big boys that the potential of what we have produced works, is viable and more importantly profitable.
I'm reminded of the situation James Dyson found himself in. His idea worked he knew that but until he had built a working model the finance he needed always eluded him. In bio's case we have the film we have the machines, we know they work we just need to show them. Fmc are a whisker away from their end game with Magenta but if we can enhance that with our own products in the different styles of film and packaging then i'm of the opimion that maybe COD's rocket will have firmly left the lauch pad. The RNS has if you like started the engines and the countdown is well underway.